CTS Corporation Announces Appointment of Kimberly Banks MacKay to its Board of Directors

Core Viewpoint - CTS Corporation has appointed Kimberly Banks MacKay to its Board of Directors, effective November 5, 2025, enhancing its governance and strategic capabilities [1][3]. Group 1: Appointment Details - Kimberly Banks MacKay brings over 30 years of experience in multinational companies and currently serves as SVP, General Counsel, and Corporate Secretary at West Pharmaceutical Services, Inc. [2] - MacKay will be a member of the Nominating, Governance and Sustainability Committee, as well as the Technology and Transactions Committee [1]. Group 2: Company Background - CTS Corporation is a leading designer and manufacturer of products that "Sense, Connect, and Move," with operations in North America, Europe, and Asia [4]. - The company provides engineered products to key markets including aerospace/defense, industrial, medical, and transportation [4]. Group 3: Leadership Perspective - Kieran O'Sullivan, Chairman, President, and CEO of CTS, expressed that MacKay's extensive experience in healthcare and global business leadership will be a valuable addition to the board [3].